News
Medscape Cardiology | theheart.org is proud to be at the forefront of the Heart Failure Society of America (HFSA) Annual ...
Boehringer Ingelheim’s Hernexeos (zongertinib) has been granted accelerated approval by the US Food and Drug Administration ...
I recently discussed this subject with Aidan Metzinger, Senior Director, Pfizer Marketing Excellence & Academy, who agrees: ...
The US Food and Drug Administration (FDA) has approved Celltrion’s intravenous (IV) formulation of Avtozma (tocilizumab-anoh) ...
Discover the key barriers to retention in obesity and weight-management trials and explore actionable, patient-centered ...
The NHS has announced that it will fast-track patients with advanced head and neck cancers in England into a clinical trial ...
The US Food and Drug Administration (FDA) has granted accelerated approval to Jazz Pharmaceuticals’ Modeyso (dordaviprone) as ...
AbbVie and Genmab’s epcoritamab has shown promise as part of a combination treatment for relapsed or refractory follicular ...
Empathy is a core capability, regardless of function – our ability to connect with others and understand how information is ...
Santhera Pharmaceuticals (SIX: SANN) announces the signing of an exclusive agreement with Uniphar to manage the distribution of AGAMREE® (vamorolone) in the United Arab Emirates, the Kingdom of Saudi ...
Let’s be honest, ‘client service’ is one of the most lifeless phrases in our industry. It confines people to their accounts and frames relationships as ...
Global non-profit organisation DEBRA Research and Queen Mary University of London have entered into a partnership aimed at advancing drug development for epidermolysis bullosa (EB).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results